Northern Trust Corp Iovance Biotherapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 2,248,576 shares of IOVA stock, worth $20.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,248,576

Previous 2,166,958 3.77%

Holding current value

$20.4 Million

Previous $17.4 Million 21.49%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.28 - $11.9 $594,179 - $971,254	81,618 Added 3.77%	2,248,576 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$7.78 - $14.19 $469,803 - $856,877	-60,386 Reduced 2.71%	2,166,958 $17.4 Million
Q1 2024 May 14, 2024	BUY	$7.59 - $17.47 $337,504 - $776,838	44,467 Added 2.04%	2,227,344 $33 Million
Q4 2023 Feb 13, 2024	BUY	$3.3 - $8.89 $626,003 - $1.69 Million	189,698 Added 9.52%	2,182,877 $17.7 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $803,329 - $1.59 Million	180,930 Added 9.98%	1,993,179 $9.07 Million
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $2.77 Million - $4.68 Million	516,454 Added 39.86%	1,812,249 $12.8 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $1.46 Million - $2.18 Million	-264,857 Reduced 16.97%	1,295,795 $7.92 Million
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $108,409 - $192,900	-19,290 Reduced 1.22%	1,560,652 $9.97 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $163,487 - $224,902	-17,155 Reduced 1.07%	1,579,942 $15.1 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $6.38 Million - $18.3 Million	999,410 Added 167.21%	1,597,097 $17.6 Million
Q1 2022 May 13, 2022	SELL	$12.38 - $19.1 $121,509 - $187,466	-9,815 Reduced 1.62%	597,687 $9.95 Million
Q4 2021 Feb 08, 2022	SELL	$16.55 - $27.63 $243,483 - $406,492	-14,712 Reduced 2.36%	607,502 $11.6 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $762,962 - $998,411	-37,492 Reduced 5.68%	622,214 $15.3 Million
Q2 2021 Aug 13, 2021	SELL	$16.33 - $33.07 $261,328 - $529,219	-16,003 Reduced 2.37%	659,706 $17.2 Million
Q1 2021 May 12, 2021	BUY	$28.67 - $52.59 $66,227 - $121,482	2,310 Added 0.34%	675,709 $21.4 Million
Q4 2020 Feb 11, 2021	SELL	$28.04 - $50.26 $218,179 - $391,073	-7,781 Reduced 1.14%	673,399 $31.2 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $353,285 - $462,135	-12,731 Reduced 1.83%	681,180 $22.4 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $21.3 Million - $32.1 Million	-783,629 Reduced 53.04%	693,911 $19 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $358,070 - $711,926	18,325 Added 1.26%	1,477,540 $44.2 Million
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $366,197 - $599,993	-20,401 Reduced 1.38%	1,459,215 $40.4 Million
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $1.58 Million - $2.29 Million	88,015 Added 6.32%	1,479,616 $26.9 Million
Q2 2019 Aug 13, 2019	BUY	$9.78 - $24.52 $96,919 - $242,993	9,910 Added 0.72%	1,391,601 $34.1 Million
Q1 2019 May 13, 2019	BUY	$8.41 - $11.26 $212,806 - $284,923	25,304 Added 1.87%	1,381,691 $13.1 Million
Q4 2018 Feb 12, 2019	BUY	$7.51 - $11.93 $2.17 Million - $3.45 Million	289,091 Added 27.09%	1,356,387 $12 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $543,903 - $855,741	48,347 Added 4.74%	1,067,296 $12 Million
Q2 2018 Sep 18, 2018	SELL	$12.45 - $16.95 $72,857 - $99,191	-5,852 Reduced 0.57%	1,018,949 $13 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $1.9 Million - $2.59 Million	152,816 Added 17.53%	1,024,801 $13.1 Million
Q1 2018 May 09, 2018	BUY	$8.1 - $19.5 $1.14 Million - $2.74 Million	140,696 Added 19.24%	871,985 $14.7 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $547,255 - $761,219	82,294 Added 12.68%	731,289 $5.85 Million
Q3 2017 Nov 13, 2017	BUY	$4.45 - $8.55 $2.89 Million - $5.55 Million	648,995	648,995 $5.03 Million

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.43B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Iovance Biotherapeutics, Inc. Transaction History